|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
CTRI |
|
Last refreshed on:
|
24 May 2021 |
|
Main ID: |
CTRI/2021/04/032943 |
|
Date of registration:
|
19-04-2021 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Study of physiological parameters in COVID-19 Disease
|
|
Scientific title:
|
Retrospective Cohort Study of physiological parameters in COVID-19 Disease |
|
Date of first enrolment:
|
02-06-2021 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Not Yet Recruiting |
|
URL:
|
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54906 |
|
Study type:
|
Observational |
|
Study design:
|
Cluster Randomized Trial
Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
India
| | | | | | | |
|
Contacts
|
|
Name:
|
Dr Krishnakant Balasaheb Patil
|
|
Address:
|
Dept of Physiology Symbiosis Medical College for Women, Lavale, Hill Base, Symbiosis International Deemed University Pune
412115
Pune, MAHARASHTRA
India |
|
Telephone:
|
9689304497 |
|
Email:
|
drkrishnakant_patil@rediffmail.com |
|
Affiliation:
|
Symbiosis Medical College for Women Lavale Pune |
|
|
Name:
|
Dr Krishnakant Balasaheb Patil
|
|
Address:
|
Symbiosis Medical College for Women, Dept of Physiology, Lavale Pune
412115
Pune, MAHARASHTRA
India |
|
Telephone:
|
9689304497 |
|
Email:
|
drkrishnakant_patil@rediffmail.com |
|
Affiliation:
|
Symbiosis Medical College for Women Lavale Pune |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Male and female COVID swab positive patients having age â?¥ 18 year
Exclusion criteria: Exclusion Criteria:
Patients on drug affecting cardiac function( altering ECG waves) :Antiarrhythmic drugs: Disopyramide, Propafenone and flecainide, Amiodarone, Beta blockers, Digitalis, HCQ, Quinidine, Anthracycline Antibiotics- doxorubicin and daunorubicin
Diagnosed chronic heart diseases: like Chronic ischemic changes, valvular disorder, cardiac hypertrophies, COPD, Congenital heart disease
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
|
Health Condition 1: A00-B99- Certain infectious and parasitic diseases
Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
|
|
Primary Outcome(s)
|
Weather ECG within 1 day of hospital admission can be used as prognostic marker or not will be clear. There might be significant changes in physiological variables in COVID- 19 patients and when these changes will be analyzed statistically, we might get significant results, which may be helpful to clinicians to treat reversible cardiovascular complications.Timepoint: Data Collection 1 month
Data Entry & Compilation 15 days
Data Analysis 15 days
Manuscript Preparation 1 month
|
|
Secondary Outcome(s)
|
|
Clinical profile of COVID-19 will be clearTimepoint: Within 6 months
|
|
Source(s) of Monetary Support
|
|
Symbiosis Medical College for Women,Symbiosis International Deemed University, Lavale, Tal: Mulshi, Dist: Pune, Maharashtra, India
|
|
Ethics review
|
Status: Approved
Approval date: 10/08/2020
Contact:
Institutional Research Committee Symbiosis Medical College for Women Pune
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|